NO982582D0 - Procedure for treating pain - Google Patents
Procedure for treating painInfo
- Publication number
- NO982582D0 NO982582D0 NO982582A NO982582A NO982582D0 NO 982582 D0 NO982582 D0 NO 982582D0 NO 982582 A NO982582 A NO 982582A NO 982582 A NO982582 A NO 982582A NO 982582 D0 NO982582 D0 NO 982582D0
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- treating pain
- pain
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Processing Of Meat And Fish (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US831395P | 1995-12-07 | 1995-12-07 | |
| US831295P | 1995-12-07 | 1995-12-07 | |
| US831995P | 1995-12-07 | 1995-12-07 | |
| US831895P | 1995-12-07 | 1995-12-07 | |
| US829595P | 1995-12-07 | 1995-12-07 | |
| US829895P | 1995-12-07 | 1995-12-07 | |
| US830695P | 1995-12-07 | 1995-12-07 | |
| PCT/US1996/019390 WO1997020556A1 (en) | 1995-12-07 | 1996-12-05 | Method for treating pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO982582D0 true NO982582D0 (en) | 1998-06-05 |
| NO982582L NO982582L (en) | 1998-08-03 |
Family
ID=27567403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO982582A NO982582L (en) | 1995-12-07 | 1998-06-05 | Procedure for the treatment of pain |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0866702A4 (en) |
| JP (1) | JP2000501711A (en) |
| KR (1) | KR19990071977A (en) |
| CN (1) | CN1208348A (en) |
| AU (1) | AU715645B2 (en) |
| CA (1) | CA2239732A1 (en) |
| CZ (1) | CZ174598A3 (en) |
| EA (1) | EA199800535A1 (en) |
| HU (1) | HUP0000110A3 (en) |
| IL (1) | IL124786A0 (en) |
| NO (1) | NO982582L (en) |
| NZ (1) | NZ324594A (en) |
| PL (1) | PL327144A1 (en) |
| WO (1) | WO1997020556A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000075140A1 (en) | 1999-06-04 | 2000-12-14 | Eli Lilly And Company | 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist |
| US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| JP6371463B2 (en) | 2014-07-17 | 2018-08-08 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド | Immediate release abuse deterrent liquid filler form |
| EP3209282A4 (en) | 2014-10-20 | 2018-05-23 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
| AU2020226870A1 (en) * | 2019-02-22 | 2021-09-09 | Karuna Therapeutics, Inc. | Compounds and methods of deuterated xanomeline for treating neurological disorders |
| WO2021097427A1 (en) | 2019-11-15 | 2021-05-20 | Karuna Therapeutics, Inc. | Xanomeline derivatives and methods for treating neurological disorders |
| CN115974863A (en) * | 2021-10-14 | 2023-04-18 | 南京迈诺威医药科技有限公司 | Malate of xanomeline derivative, crystal form A, preparation method of malate, and application of crystal form A |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| DK198590D0 (en) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE |
| US5527813A (en) * | 1990-08-21 | 1996-06-18 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| US5376668A (en) * | 1990-08-21 | 1994-12-27 | Novo Nordisk A/S | Heterocyclic compounds |
| WO1993014089A1 (en) * | 1992-01-13 | 1993-07-22 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| US5605701A (en) * | 1995-02-17 | 1997-02-25 | Eli Lilly And Company | Transdermal formulation |
-
1996
- 1996-12-05 EA EA199800535A patent/EA199800535A1/en unknown
- 1996-12-05 PL PL96327144A patent/PL327144A1/en unknown
- 1996-12-05 IL IL12478696A patent/IL124786A0/en unknown
- 1996-12-05 AU AU11476/97A patent/AU715645B2/en not_active Ceased
- 1996-12-05 WO PCT/US1996/019390 patent/WO1997020556A1/en not_active Application Discontinuation
- 1996-12-05 EP EP96942906A patent/EP0866702A4/en not_active Withdrawn
- 1996-12-05 CN CN96199835A patent/CN1208348A/en active Pending
- 1996-12-05 HU HU0000110A patent/HUP0000110A3/en unknown
- 1996-12-05 KR KR1019980704268A patent/KR19990071977A/en not_active Application Discontinuation
- 1996-12-05 NZ NZ324594A patent/NZ324594A/en unknown
- 1996-12-05 CZ CZ981745A patent/CZ174598A3/en unknown
- 1996-12-05 CA CA002239732A patent/CA2239732A1/en not_active Abandoned
- 1996-12-05 JP JP09521436A patent/JP2000501711A/en active Pending
-
1998
- 1998-06-05 NO NO982582A patent/NO982582L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0000110A3 (en) | 2000-09-28 |
| PL327144A1 (en) | 1998-11-23 |
| IL124786A0 (en) | 1999-01-26 |
| EP0866702A1 (en) | 1998-09-30 |
| KR19990071977A (en) | 1999-09-27 |
| NO982582L (en) | 1998-08-03 |
| EP0866702A4 (en) | 2001-07-25 |
| EA199800535A1 (en) | 1998-12-24 |
| WO1997020556A1 (en) | 1997-06-12 |
| AU1147697A (en) | 1997-06-27 |
| CN1208348A (en) | 1999-02-17 |
| CZ174598A3 (en) | 1999-01-13 |
| HUP0000110A2 (en) | 2000-06-28 |
| JP2000501711A (en) | 2000-02-15 |
| CA2239732A1 (en) | 1997-06-12 |
| AU715645B2 (en) | 2000-02-10 |
| NZ324594A (en) | 1999-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO984431D0 (en) | Procedure for treating pain | |
| NO982172D0 (en) | Use of epinastine for the treatment of pain | |
| NO976063D0 (en) | Procedure for the treatment of diabetes | |
| NO991955D0 (en) | Process for the treatment of hydrocarbons | |
| DE69618176D1 (en) | SOFT TREATED TISSUE | |
| BR9605861A (en) | Vegetable treatment | |
| NO983266D0 (en) | Distributed Treatment | |
| BR9609132A (en) | Seed composition and treatment method | |
| EP0874828A4 (en) | Composition for treating pain | |
| DE69609959D1 (en) | EXHAUST TREATMENT | |
| GB9519033D0 (en) | Treatment | |
| DE19681419T1 (en) | Treatment system | |
| DE59609662D1 (en) | HAIR TREATMENT AGENT | |
| NO984446D0 (en) | Procedure for treating pain | |
| NO982911D0 (en) | Procedure for treating depression | |
| NO983263D0 (en) | Distributed treatment | |
| IS4789A (en) | treatment Compounds | |
| NO982582D0 (en) | Procedure for treating pain | |
| NO973366D0 (en) | Procedure for the treatment of multiple sclerosis | |
| NO982562D0 (en) | Composition for the treatment of pain | |
| BR9610382A (en) | Cableo treatment composition | |
| DE59607418D1 (en) | HAIR TREATMENT | |
| ID16924A (en) | POLYLELEFIN TREATMENT METHOD | |
| DE69627052D1 (en) | Heat treatment plant | |
| DE59608075D1 (en) | INTRACORPORAL TREATMENT SYSTEM |